JP2021518438A5 - - Google Patents

Info

Publication number
JP2021518438A5
JP2021518438A5 JP2021500350A JP2021500350A JP2021518438A5 JP 2021518438 A5 JP2021518438 A5 JP 2021518438A5 JP 2021500350 A JP2021500350 A JP 2021500350A JP 2021500350 A JP2021500350 A JP 2021500350A JP 2021518438 A5 JP2021518438 A5 JP 2021518438A5
Authority
JP
Japan
Prior art keywords
composition according
composition
silodosin
azoospermia
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021500350A
Other languages
English (en)
Japanese (ja)
Other versions
JP7270901B2 (ja
JP2021518438A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/057267 external-priority patent/WO2019180217A1/en
Publication of JP2021518438A publication Critical patent/JP2021518438A/ja
Publication of JP2021518438A5 publication Critical patent/JP2021518438A5/ja
Application granted granted Critical
Publication of JP7270901B2 publication Critical patent/JP7270901B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021500350A 2018-03-23 2019-03-22 男性の避妊のための非ホルモン性組成物および方法 Active JP7270901B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
US62/763,129 2018-03-23
EP18305328 2018-03-23
EP18305328.9 2018-03-23
PCT/EP2019/057267 WO2019180217A1 (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Publications (3)

Publication Number Publication Date
JP2021518438A JP2021518438A (ja) 2021-08-02
JP2021518438A5 true JP2021518438A5 (https=) 2022-03-30
JP7270901B2 JP7270901B2 (ja) 2023-05-11

Family

ID=65955198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500350A Active JP7270901B2 (ja) 2018-03-23 2019-03-22 男性の避妊のための非ホルモン性組成物および方法

Country Status (19)

Country Link
US (3) US10912762B2 (https=)
EP (2) EP3750538B1 (https=)
JP (1) JP7270901B2 (https=)
KR (1) KR102496504B1 (https=)
CN (1) CN112074269A (https=)
AU (1) AU2019237228B2 (https=)
BR (1) BR112020018925A2 (https=)
CA (1) CA3094016C (https=)
DK (2) DK3562485T3 (https=)
ES (2) ES2989170T3 (https=)
FI (1) FI3750538T3 (https=)
IL (1) IL277372B2 (https=)
MA (1) MA53626B1 (https=)
MX (1) MX2020009937A (https=)
PL (2) PL3562485T3 (https=)
PT (1) PT3562485T (https=)
SG (1) SG11202008794TA (https=)
UA (1) UA128502C2 (https=)
WO (1) WO2019180217A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3750538B1 (en) * 2018-03-23 2024-08-14 Pharmajor International Non-hormonal methods for male contraception comprising (r)-silodosin
IL319287A (en) 2022-11-23 2025-04-01 Pharmajor Incorporated Silodosin formulations with different release and their use in male contraceptive methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
ATE474580T1 (de) 2000-02-15 2010-08-15 Bayer Schering Pharma Ag Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
UA95085C2 (ru) * 2005-09-29 2011-07-11 Баер Шеринг Фарма Акциенгезельшафт Применение варденафила для лечения урологических расстройств
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ
US20100098735A1 (en) * 2006-10-05 2010-04-22 Rajesh Jain Injectable depot compositions and its process of preparation
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
MX2009009230A (es) 2007-02-28 2009-11-26 Kissei Pharmaceutical Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna.
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) * 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
WO2016051782A1 (ja) 2014-09-30 2016-04-07 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
EP3750538B1 (en) * 2018-03-23 2024-08-14 Pharmajor International Non-hormonal methods for male contraception comprising (r)-silodosin

Similar Documents

Publication Publication Date Title
JP2005512995A5 (https=)
JP2013530220A (ja) ダポキセチンを含む時間差徐放性経口投与型の薬学的組成物
JP2016504384A5 (https=)
JP2013529665A5 (https=)
JP2009536176A5 (https=)
CN104684553A (zh) 治疗多发性硬化症的组合疗法
JP2008543936A5 (https=)
JP2021088575A5 (https=)
RU2009102443A (ru) Фармацевтический препарат для контрацепции и для предотвращения риска врожденных пороков развития
JP2021502382A5 (https=)
JP2021518438A5 (https=)
IL272834B2 (en) Amantadine compositions, preparations thereof, and methods of use
JP2020536931A (ja) 二層医薬錠剤製剤
ES2989170T3 (es) Métodos no hormonales para la anticoncepción masculina que comprenden (R)-silodosina
US12186325B2 (en) Treatment and prevention of premature ejaculation (PE)
JP4695326B2 (ja) 鼻炎用医薬組成物
NZ767741B2 (en) Non-hormonal compositions and methods for male contraception
JP2009235093A (ja) 鼻炎用医薬組成物
JP2024084670A5 (https=)
HK40053063A (en) Treatment and prevention of premature ejaculation (pe)
HK40053063B (en) Treatment and prevention of premature ejaculation (pe)
HK40041318A (en) Non-hormonal methods for male contraception comprising (r)-silodosin
HK40041318B (en) Non-hormonal methods for male contraception comprising (r)-silodosin
Matter Drug Combo Better for Migraine Treatment
OA21941A (en) Non-hormonal compositions and methods for male contraception.